| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |